Immix Biopharma Inc
NASDAQ:IMMX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Immix Biopharma Inc
NASDAQ:IMMX
|
US |
|
Banque Cantonale Vaudoise
F:B1V1
|
CH |
|
S
|
Starbucks Corp
XMUN:SRB
|
US |
|
F
|
Fiserv Inc
DUS:FIV
|
US |
|
Alimentation Couche-Tard Inc
OTC:ANCTF
|
CA |
|
M
|
MillerKnoll Inc
XMUN:MHR
|
US |
|
ChampionX Corp
NASDAQ:CHX
|
US |
|
Cobram Estate Olives Ltd
OTC:CBOAF
|
AU |
|
Amicus Therapeutics Inc
NASDAQ:FOLD
|
US |
|
Siem Offshore Inc
OSE:SEA1
|
NO |
|
N
|
Namchow Holdings Co Ltd
TWSE:1702
|
TW |
|
Beyondspring Inc
NASDAQ:BYSI
|
US |
|
BTC Digital Ltd
NASDAQ:BTCT
|
CN |
|
Central Petroleum Ltd
ASX:CTP
|
AU |
|
T
|
Tempur Sealy International Inc
XBER:TPD
|
US |
|
Fugro NV
F:F3DC
|
NL |
|
M
|
Mckesson Corp
XMUN:MCK
|
US |
|
Teva Pharmaceutical Industries Ltd
F:TEV
|
IL |
|
Exor NV
AEX:EXO
|
NL |
|
C
|
Casella Waste Systems Inc
F:WA3
|
US |
|
P
|
PT Menthobi Karyatama Raya Tbk
IDX:MKTR
|
ID |
|
Innate Pharma SA
PAR:IPH
|
FR |
|
ABC Arbitrage SA
F:9BA
|
FR |
Wall St Price Targets
IMMX Price Targets Summary
Immix Biopharma Inc
According to Wall Street analysts, the average 1-year price target for
IMMX is 21.71 USD with a low forecast of 15.15 USD and a high forecast of 28.35 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IMMX's stock price target?
Price Target
21.71
USD
According to Wall Street analysts, the average 1-year price target for
IMMX is 21.71 USD with a low forecast of 15.15 USD and a high forecast of 28.35 USD.